EVICT-VR Study
Cross-source consensus on EVICT-VR Study from 1 sources and 5 claims.
1 sources · 5 claims
Preparation
Evidence quality
Other
Other
Other
Highlighted claims
- EVICT-VR enrolls patients with vitreoretinal pathology warranting surgery, including EVD survivors and non-EVD uveitis controls. — Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation
- All EVICT-VR participants undergo pars plana vitrectomy under strict infection prevention and control precautions. — Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation
- Laboratory technicians in EVICT-VR remain masked to patient group status. — Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation
- Patients unlikely to gain meaningful visual acuity improvement or unable to undergo surgery are excluded from EVICT-VR. — Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation
- Aim 2 compares the proportion of EVD survivors with detectable vitreous EBOV RNA to controls using chi-squared or Fisher exact testing. — Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation